Supernus Wearable Device for Dosing Parkinson’s Drug Lands Long-Awaited FDA Approval

Supernus Pharmaceuticals’ Onapgo provides a continuous infusion of apomorphine to manage “off” periods experienced by Parkinson’s disease patients. Approval of Onapgo comes after the FDA twice turned back applications for the drug/device combination product. The post Supernus Wearable Device for Dosing Parkinson’s Drug Lands Long-Awaited FDA Approval appeared first on MedCity News.

Read More

Is Caring Productive?

That is the title of a paper by Longo et al. (2025). The authors use dynamic panel data on Adult Social Care (ASC) in the UK. What is ASC include: A quick explainer about ASC in the UK: In England, there are 152 upper-tier local authorities (LAs) who are responsible for publicly-funded ASC services. Access…

Read More